Exeltis USA Overview
- Founded
-
1972
- Status
-
Acquired/Merged
- Employees
-
4,000
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
- Investments
-
1
Exeltis USA General Information
Description
Provider of prescription pharmaceutical and nutraceutical products. The company's products are sold through sales representatives to the eastern United States, as well as several foreign countries. Its main products are vitamins, respiratory care, anti-infective, and pain relief treatments.
Contact Information
Website
womenshealth.exeltisusa.com
Formerly Known As
Everett Laboratories
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Parent Company
Insud Pharma
Primary Office
- 29 Spring Street
- West Orange, NJ 07052
- United States
+1 (973) 000-0000
Exeltis USA Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Exeltis USA Patents
Exeltis USA Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20190021385-A1 | Orally dissolvable compositions for nutrition supplementation | Abandoned | 21-Jul-2017 | 0000000000 | 0 |
| CA-3011848-A1 | Orally dissolvable compositions for nutrition supplementation | Abandoned | 21-Jul-2017 | 0000000000 | |
| US-20170202802-A1 | Compositions, kits and methods for nutrition supplementation | Abandoned | 20-Jan-2016 | 0000000000 | |
| US-20150305386-A1 | Compositions for nutritional supplementation | Abandoned | 28-Apr-2014 | 000000000 | |
| US-20150258020-A1 | Chewable tablets comprising levonorgestrel | Abandoned | 17-Mar-2014 | A61K9/0056 |
Exeltis USA Executive Team (5)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Everett Felper | President & Founder | ||
| Terry Felper - Giordano | Chief Operating Officer | ||
| John Giordano | Executive Vice President |
Exeltis USA Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Exeltis USA Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Exeltis USA Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 000 0 | 16-Dec-2013 | 0000000000 | Pharmaceuticals | 00000 000 |